Basifungin

This classification denotes an antifungal agent with the molecular formula C60H92N8O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier VV0USO6I6U, chemically known as valine, 3-hydroxy-n-(n-(n-(n-(1-(n-(n-(n-(2-hydroxy-3-methyl-1-oxopentyl)-n-methylvalyl)phenylalanyl)-n-methylphenylalanyl)prolyl)alloisoleucyl)-n-methylvalyl)leucyl)-n-methyl-, alpha-1-lactone but generally known as basifungin, which bears US NIH Compound Identifier 72050. European Medicines Agency schedules Basifungin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06107MIG. The term BASIFUNGIN is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). BASIFUNGIN is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule basifungin under HS 29419000 and SITC 54139. As of Q4 2014, BASIFUNGIN remains the US FDA Preferred Term for this commodity. Basifungin bears US NLM identifiers UMLS ID C0382347 and NCI Concept Code C90723. SMILES: O=C1NC(C(CC)C)C(=O)N(C(C(C)C)C(=O)NC(CC(C)C)C(=O)N(C(C(O)(C)C)C(=O)OC(C(CC)C)C(=O)N(C(C(C)C)C(=O)NC(C(=O)N(C(C(=O)N2C1CCC2)CC1CCCCC1)C)CC1CCCCC1)C)C)C.